These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29101176)

  • 1. VEGF nanoparticles repair the heart after myocardial infarction.
    Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.
    Chung HJ; Kim JT; Kim HJ; Kyung HW; Katila P; Lee JH; Yang TH; Yang YI; Lee SJ
    J Control Release; 2015 May; 205():218-30. PubMed ID: 25681051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.
    Awada HK; Johnson NR; Wang Y
    J Control Release; 2015 Jun; 207():7-17. PubMed ID: 25836592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.
    Zhu H; Jiang X; Li X; Hu M; Wan W; Wen Y; He Y; Zheng X
    Heart Vessels; 2016 Jun; 31(6):963-75. PubMed ID: 26142379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
    Adachi M; Watanabe M; Kurata Y; Inoue Y; Notsu T; Yamamoto K; Horie H; Tanno S; Morita M; Miake J; Hamada T; Kuwabara M; Nakasone N; Ninomiya H; Tsuneto M; Shirayoshi Y; Yoshida A; Nishimura M; Yamamoto K; Hisatome I
    Circ J; 2019 Oct; 83(11):2282-2291. PubMed ID: 31527337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
    Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
    J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.
    Lu ZX; Mao LL; Lian F; He J; Zhang WT; Dai CY; Xue S; Lu WG; Zhu HS
    BMC Cardiovasc Disord; 2014 Apr; 14():53. PubMed ID: 24742302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction.
    Guo HD; Cui GH; Yang JJ; Wang C; Zhu J; Zhang LS; Jiang J; Shao SJ
    Biochem Biophys Res Commun; 2012 Jul; 424(1):105-11. PubMed ID: 22732415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
    Liu CD; Tu XF; Chen F
    Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
    Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing.
    Arokiaraj MC
    BMC Cardiovasc Disord; 2017 Jul; 17(1):209. PubMed ID: 28754088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.
    Wang Y; Liu XC; Zhao J; Kong XR; Shi RF; Zhao XB; Song CX; Liu TJ; Lu F
    Tex Heart Inst J; 2009; 36(2):89-97. PubMed ID: 19436800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local intramyocardial delivery of bioglass with alginate hydrogels for post-infarct myocardial regeneration.
    Qi Q; Zhu Y; Liu G; Yuan Z; Li H; Zhao Q
    Biomed Pharmacother; 2020 Sep; 129():110382. PubMed ID: 32590191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis.
    Silva EA; Mooney DJ
    J Thromb Haemost; 2007 Mar; 5(3):590-8. PubMed ID: 17229044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.
    Wu M; Pokreisz P; Swinnen M; Caluwe E; Gillijns H; Vanden Driessche N; Casazza A; Verbeken E; Collen D; Janssens S
    J Cardiovasc Transl Res; 2017 Aug; 10(4):348-358. PubMed ID: 28397162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
    Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
    Takeda Y; Uemura S; Iwama H; Imagawa K; Nishida T; Onoue K; Takemoto Y; Soeda T; Okayama S; Somekawa S; Ishigami K; Takaoka M; Kawata H; Kubo A; Horii M; Nakajima T; Saito Y
    Circ J; 2009 Sep; 73(9):1674-82. PubMed ID: 19602778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal release of VEGF from biodegradable polylactic-co-glycolic acid microspheres induces angiogenesis in chick chorionic allantoic membrane assay.
    Qutachi O; Bullock AJ; Gigliobianco G; MacNeil S
    Int J Pharm; 2019 Apr; 561():236-243. PubMed ID: 30853484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.